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11.1  Background
Methaqualone, a quinazolone derivative was first synthesized in 1951, and used  medically 
as a hypnotic for the short-term treatment of insomnia, and also as a recreational drug. 
It acts as a central nervous system depressant in a similar manner to barbiturates. It was 
commonly marketed as Quaaludes and Mandrax (containing methaqualone base 250 
mg, and diphenhydramine hydrochloride 25 mg) in the 1960s and 1970s and also as 
Malsed, Malsedin, and Renoval in the United Kingdom (see the Multilingual  Dictionary 
of Narcotic Drugs and Psychotropic Substances under International Control (MLD), 
www.unodc.org). Due to abuse, addiction and a higher potential to create dependence 
than the barbiturates, methaqualone is no longer prescribed in medicine and it is under 
international control (Schedule II of the Convention on Psychotropic Substances 1971). 
The detrimental effects of hypnotic dependence on methaqualone arise particularly 
from the persistence of effects such as ataxia, dysarthia, mental impairment, confusion 
and poor judgement. Side effects of treatment with methaqualone or its hydrochloride 
in therapeutic doses include headaches, hangovers, dizziness, drowsiness, anorexia, 
nausea and gastro-intestinal discomfort, dry mouth, restlessness and sweating. Skin 
reactions have also been reported. Methaqualone is now only largely illicitly produced 
in clandestine laboratories. Its main use is as a recreational drug taken orally as a tablet 
formulation and often smoked when mixed with cannabis (marijuana).
Mecloqualone, an analogue of methaqualone, was synthesized in 1960 and was  available 
as a legitimately dispensed hypnotic, especially in France under the proprietary names 
Nubarene and Casfen (refer to MLD, www.unodc.org) and some other European coun-
tries. It was never as widely used as methaqualone and is also no longer prescribed 
because of concerns about its potential abuse and overdose.
1.2  Purpose and use of  the manual
The present manual is one in a series of similar UNODC publications dealing with the 
identification and analysis of various types of drugs under international control. These 
manuals are the outcome of a programme pursued by UNODC since the early 1980s, 
aimed at the harmonization and establishment of recommended methods of analysis 
for national drug analysis laboratories.
In line with the overall objective of this series of UNODC publications, the present 
manual suggests approaches that may assist drug analysts in the selection of methods 
appropriate to the sample under examination and provide data suitable for the purpose 
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at hand, leaving room also for adaptation to the level of sophistication of different 
laboratories and the various legal needs.
Any new method that is about to be used in the reader’s laboratory must be 
 validated and/or verified prior to routine use.
The methods described here should be understood as guidance, that is, minor  modifications 
to suit local circumstances should normally not change the validity of the results. 
The choice of the methodology and approach to analysis as well as the decision as to 
whether or not additional methods are required remain with the analyst and may also 
be dependent on the availability of appropriate instrumentation and the level of legally 
acceptable proof in the jurisdiction within which the analyst works.
Attention is also drawn to the vital importance of the availability to drug analysts of 
reference materials and literature on drugs of abuse and analytical techniques. Moreover, 
the analyst must of necessity keep abreast of current trends in drug analysis, consistently 
following current analytical and forensic science literature.
UNODC Laboratory and Scientific Section welcomes observations on the contents and 
usefulness of the present manual. Comments and suggestions may be addressed to:
Laboratory and Scientific Section
United Nations Office on Drugs and Crime
Vienna International Centre
P.O. Box 500
1400 Vienna
Austria
Fax: (+43-1) 26060-5967
E-mail: Lab@unodc.org
All manuals, as well as guidelines and other scientific-technical publications may be 
requested by contacting the address above.
32.1  Illicit manufacture
The synthesis of methaqualone usually involves uncomplicated one and two step  reactions 
that are easily performed in clandestine laboratories [1]. A one-step reaction is  carried 
out by refluxing anthranilic acid, acetic acid (or acetic anhydride) and  o-toluidine 
 (o-chloroaniline for mecloqualone). Polyphosphoric acid is added to remove water. 
 Purification is accomplished by dissolving the solid residue in methanol and  precipitation 
of the hydrochloride salt from a methanol-diethyl ether solution.
The two-step reaction involves the preparation of N-acetylanthranilic acid from 
 anthranilic acid and acetic anhydride followed by condensation with o-toluidine in the 
presence of phosphorus trichloride. Substituting o-chloroaniline for o-toluidine would 
produce mecloqualone.
According to the International Narcotics Control Board (INCB), the cumulative global 
seizures of the precursors since 2000 were 10.4 metric tons of N-acetylanthranilic acid 
and 34.5 metric tons of anthranilic acid, enough to produce approximately 42.8 metric 
tons of methaqualone. The total seizures of these precursors have varied dramatically 
from between 5 kg to 25.6 metric tons annually, since 2000. The largest multi-ton 
 seizures have been reported in China (N-acetylanthranilic acid), Mozambique and 
South Africa (anthranilic acid).
Clandestinely produced methaqualone appears on the illicit market as a brown, grey or 
black tacky powder with 30-70 per cent purity. The colour depends on the amount of 
 impurities present. Methaqualone is also used as a cutting agent for heroin and can be 
present in seizures of heroin up to a concentration of about 30 per cent.
2.2  Main  trends and patterns  in  illegal  trafficking
Data related to the use and seizures of methaqualone and mecloqualone, their  chemical 
precursors and clandestine manufacture are sporadic and inconsistent making the 
analysis of trends difficult.
Currently there are no estimates of global lifetime or past-year use of this drug.  However, 
most use is assumed to occur in South Africa. In 2006, a survey of students in Cape 
Town, South Africa aged 13-17 years found a lifetime prevalence of 2.6 per cent and 
a past-year use of 1.1 per cent for this drug. Treatment for the drug accounted for 
 approximately 4 per cent of all drug treatment cases in South Africa in 2007.
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Since 2000, only 22 countries have reported seizures of methaqualone, of which half 
were located in Africa’s southern and central subregions. The cumulative amount 
seized globally since 2000 is approximately 37.5 metric tons, the majority of which 
was seized in 2001-2002. India (a large producer of methaqualone) and South Africa 
(a large consumer of methaqualone) account for 47 per cent and 44 per cent of global 
seizures respectively.
Since 2000, reports of illicit manufacture have come from only four countries: China, 
India, Kenya and South Africa. During that time, 58 laboratories have been reported 
dismantled, of which 93 per cent (54) were reported in South Africa. The number of 
clandestine methaqualone laboratories in South Africa has declined since their peak in 
2003-2004 when 15 laboratories were dismantled on average per year.
53.1  Methaqualone
2-methyl-3-o-tolyl-4-(3H)-quinazolinone
Sch. II, 1971
Empirical formula: C15H14N2O
CAS No.: 72-44-6
Molecular weight: 250.7 g/mol
Melting point freebase: 113-115˚C
Melting point HCI salt: 235-237˚C
Physical appearance:  in its pure 
form, occurs as 
a white 
crystalline 
powder
Solubility  in: Water Ethanol Diethyl  ether Chloroform
Methaqualone base insoluble soluble soluble soluble
Methaqualone 
 hydrochloride salt
soluble soluble insoluble soluble
3.2  Mecloqualone
3-(o-chlorophenyl)-2-methyl-4-(3H)-
quinazolinone
Sch. II, 1971
Empirical formula: C15H11CIN2O
CAS No.: 340-57-8
Molecular weight: 270.7 g/mol
Melting point freebase: 126-128˚C
Melting point HCI salt: 239-241˚C
Physical appearance:  in its pure 
form, occurs as 
a white 
crystalline 
powder
Solubility  in: Water Ethanol Diethyl  ether Chloroform
Mecloqualone base insoluble soluble soluble very soluble
Mecloqualone 
 hydrochloride salt
soluble soluble insoluble soluble
Both methaqualone and mecloqualone may be encountered as powders, tablets or 
 capsules and may be present as the base or the hydrochloride salt in these formulations.

7Generally, in attempting to establish the identity of a controlled drug in suspect  material, 
the analytical approach must entail the determination of at least two uncorrelated 
 parameters. One of which should provide information on the chemical structure of the 
analyte (for example, IR, MS; or tandem methods such as GC-MS).
It is recognized that the selection of these parameters in any particular case would take 
into account the drug involved and the laboratory resources available to the analyst. 
It is also accepted that unique requirements in different jurisdictions may dictate the 
actual practices followed by a particular laboratory.
4.1  Sampling
The principal reason for a sampling procedure is to permit an accurate and  meaningful 
chemical analysis. Because most methods–qualitative and quantitative–used in  forensic 
drug analysis laboratories require very small aliquots of material, it is vital that 
these small aliquots be representative of the bulk from which they have been drawn. 
Sampling should conform to the principles of analytical chemistry, as laid down, for 
example, in national pharmacopoeias or by regional or international organizations. For 
general aspects of qualitative sampling of multi-unit samples, refer to the Guidelines 
on  Representative Drug Sampling (www.unodc.org). For seized material with obvious 
external characteristics, a sampling method based on the Bayes’ model may be preferred 
over the hypergeometric approach.
The use of an approved sampling system also helps to preserve valuable resources and 
time by reducing the number of determinations needed. It is recognized that there may 
be situations where, for legal reasons, the normal rules of sampling and homogeniza-
tion cannot be followed.
4.1.1  Extraction and  sample preparation
Since methaqualone/mecloqualone exhibits are mostly from illicit manufacture, a 
simple extraction procedure may not work in all cases because of interference from 
raw materials, intermediates and by-products from clandestine routes. Nevertheless 
the following procedure provides a fast and simple way of isolating methaqualone or 
mecloqualone from most powder, tablet or capsule samples.
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The representative sample of powder, tablet or capsule is suspended in 1M sodium 
bicarbonate solution. Methaqualone/mecloqualone (as the free base) may be extracted 
quantitatively with several portions of dichloromethane. The combined organic layers 
are filtered, dried over anhydrous sulphate and evaporated.
Due to the trace amounts of drug usually present on glassware and other equipment 
found in clandestine laboratories, the nature of the analysis should be geared towards 
conclusive analytical procedures rather than presumptive tests. Wash the syringe or 
glassware with a minimum amount of dichloromethane or methanol, concentrate to 
dryness under a stream of nitrogen and proceed with selected tests. Organic layers 
may be filtered, dried over anhydrous sulphate and reduced to dryness under a stream 
of nitrogen gas.
4.2  Examination
4.2.1  Colour  test  [2,  3]
(a)  Cobalt thiocyanate test
Reagent A: 16 per cent hydrochloric acid solution
Reagent B: 2.5 g cobalt (II) thiocyanate in 100 ml of water
Method
Place a small amount of the suspected material into a test-tube. Add 1 drop of reagent A 
and 1 drop of reagent B. A blue colour indicates the possible presence of methaqualone 
or mecloqualone.
(b)   Fischer-Morris test
Reagent A: Concentrated formic acid (88 per cent)
Reagent B:  5 per cent aqueous sodium nitrite solution
Method
Place a small amount of suspected material into a test tube. Add 7 drops of reagent A 
and then 5 drops of reagent B. Allow to stand for 1-2 minutes and then add 15-20 drops 
of chloroform. Shake, allow to stand and observe the colour of both layers.
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Table 1.  Results
Compound
Cobalt  thiocyanate 
test
Fischer-Morris  test
Water  layer Chloroform  layer
Methaqualone Blue No colour Yellow
Mecloqualone Blue No colour Yellow
Cocaine Blue Faint green Faint green
Phencyclidine Blue Tinged Tinged
Caffeine Blue No colour No colour
Heroin Blue Faint yellow Yellow
Diphenhydramine Blue Yellow No colour
Diazepam Blue green Faint yellow Faint yellow
Analytical notes
• Positive results to colour tests are only presumptive indications of the  possible 
presence of methaqualone or mecloqualone. Other controlled substances 
(cocaine, phencyclidine) and non-controlled drugs/precursors may produce 
a similar blue colour in the cobalt thiocyanate test.
• For the Fischer-Morris test, the order of addition and the ratio of drops are 
critical for obtaining the described results.
• A positive result is indicated by a yellow colour in 1-2 minutes. For meth-
aqualone and mecloqualone, the yellow colour is extracted in the lower 
chloroform layer whilst the upper aqueous layer remains colourless. This 
is a true positive and should be differentiated from the yellow colour in 
the bottom layer and a yellow or other colour in the top layer with e.g. 
diphenhydramine, diazepam or ephedrine hydrochloride.
• A negative result is that in which the bottom layer does not have a yellow 
colour, regardless of the colour of the top layer.
• The sodium nitrite reagent works equally well at room temperature or 
even when cool. It has a long shelf life without special storage conditions/
precautions.
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4.2.2  Microcrystal  test
Microcrystal tests [4] are quick, simple and extremely sensitive tests for the identifica-
tion of substances. They involve the formation of crystals from the reaction of the target 
compound with a chemical reagent, followed by the analysis of the resulting crystals 
by means of a polarizing microscope and comparison with reference material, usually 
photographs of known crystals.
Method
The simplest form of the test consists of adding a drop of the reagent to the test substance, 
followed by observing and analyzing the crystals under a polarizing microscope. In 
order to maintain an accurate record, the characteristic features of the crystals should 
be described. The most accurate record of the test results is by photographs. In the 
absence of photography, a sketch of the crystal forms is helpful.
Hanging drop  technique
This requires a cavity slide, a cover glass and the test reagent. A “microdrop”, obtained 
from a very narrow glass tube (drawn from a glass tube), of the test solution is placed 
on the cover-slip and a “microdrop” of the reagent is added, the drop being stirred 
with slight scratching of the glass to promote the formation of crystals. A cavity slide 
is ringed with gum Arabica solution, inverted over the cover-slip, and re-inverted so 
as to leave a “hanging drop”. Crystals are free to form slowly in a three-dimensional 
environment. Evaporation is prevented by the gum Arabic seal and this promotes 
regular, reproducible shapes.
Figure 1.  Typical  forms of microcrystals  [4]
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Typical forms of microcrystal can be classified into nine groups, using the descriptive 
terms above. In order to allow description of all types of microcrystals, adjectives such 
as irregular, fine or square-cut should be added to the basic terms.
Reagent I
Potassium permanganate solution: Transfer 25 g of potassium permanganate into a 
100 ml flask; add 5 drops of phosphoric acid (88-90 per cent w/w) and make up to the 
mark with water.
Result
Methaqualone gives serrated plates (figure 1).
Reagent II
Sodium carbonate solution: Transfer 5 g of sodium carbonate in a 100 ml flask and 
make up to the mark with water.
Result
Methaqualone gives bunches of prisms (figure 1).
Reagent III
Iodine-iodine solution (I-KI B): Mix 0.5 ml of solution of 10 g of iodine and 35 g 
of potassium iodine in 100 ml water, 1.8 ml glacial acetic acid and 2.2 ml of syrupy 
phosphoric acid and 1.5 ml water.
Results
Figure 2.  [reproduced  from  reference 4]
Reagent IV
Picric acid solution: Prepare a solution of 0.03 g of picric acid in a mixture of 1ml of 
glacial acid and 5 ml of 40 per cent magnesium acetate solution.
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Figure 2 [reproduced from reference 4] 
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Results
Figure 3.  [reproduced  from  reference 4]
4.2.3  Thin  layer  chromatography  (TLC)
TLC is a commonly used technique for the separation and identification of illicitly 
manufactured drugs. It is inexpensive, rapid, sensitive (sub-milligram quantities of 
analyte required), flexible in the selection of both the stationary and mobile phase and 
amenable to a wide variety of substances, in base and salt form, ranging from the most 
polar to non-polar materials. A variety of visualization techniques can be used.  However, 
in many countries it is not accepted as a single technique for drug identification.
TLC plates (stationary phases)
Coating: Silica gel G with a layer thickness of 0.25 mm and containing an inert  indicator, 
which fluoresces under UV light wavelength 254 nm (Silica gel GF254).
Note: Plates prepared by the analyst must be activated before use by placing them into 
an oven at 120°C for at least 10 to 30 minutes. Plates are then stored in a grease-free 
desiccator over blue silica gel. Heat activation is not required for commercially avail-
able coated plates.
Typical plate sizes: 20 x 20 cm, 20 x 10 cm, 10 x 5 cm (the latter should be used with 
the 10 cm side vertical with the TLC tank).
Solvent systems (mobile phases, by volume)
System A: Cyclohexane : Toluene : Diethylamine ( 75 : 15 : 10 v/v)
System B: Methanol : Concentrated ammonia solution (100 : 1.5 v/v)
Methods
Solvent systems
Prepare developing solvent systems as accurately as possible by use of pipettes,  dispensers 
and measuring cylinders. Leave the solvent system in the TLC tank for a time sufficient 
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to allow vapour phase saturation to be achieved prior to the analysis (with adsorbent 
paper-lined tanks, this takes approximately 5 minutes).
Preparation of standard solutions
These are all prepared at a concentration of 5 mg/ml in methanol and stored in a dark 
and cool place.
Sample solutions
Powder: Prepare a solution at a concentration of approximately 5 mg/ml in methanol.
Tablets:  Grind a representative number of tablets (following sampling procedure) 
to a fine powder and prepare a solution as for powder.
Capsules:  Remove the contents of a representative sample of capsules (following 
sampling procedure) and prepare a solution as for powder.
Spotting and developing
Apply as separate spots 1 µl and 5 µl aliquots of sample solution, 2 µl of the standard 
solution(s) and 2 µl of solvent (as a negative control) on the TLC plate. Spotting must 
be done carefully to avoid damaging the surface of the plate.
Analytical notes – TLC
• The starting point of the run i.e. the “spotting line” should be 2 cm from 
the bottom of the plate.
• The spacing between applications of sample (spotting points) should be 
at least 1 cm and spots should not be placed closer than 1.5 cm to the side 
edge of the plate.
• To avoid diffuse spots during development, the size of the sample spot 
should be as small as possible (2 mm).
• Allow spots to dry and place plate into solvent-saturated tank (saturation 
of the vapour phase is achieved by using solvent-saturated pads or filter 
paper as lining of the tank).
• Remove plate from the development tank as soon as possible as the solvent 
reaches the development line (10 cm from starting- line) marked beforehand; 
otherwise, diffused spots will occur.
Visualization/detection
Plates must be dried prior to visualization. The solvent can be allowed to evaporate at 
room temperature or removed with a hot air blower. It is important for proper colour 
development that all traces of diethylamine and ammonia be removed from the plate.
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Visualization methods
A. UV light at 254 nm
 Purple spots on an otherwise green-fluorescent plate are seen.
B. Acidified potassium iodoplatinate spray reagent
  Dissolve 0.25 g platinic chloride and 5 g potassium iodide in water and make up 
to 100 ml; add 5 ml of concentrated hydrochloric acid to the resulting solution. 
Bluish purple spots on a pink background are observed when the plate is spayed 
with the reagent.
Interpretation
After visualization, mark spots (e.g. by pencil) and calculate retardation factor (Rf) values.
Rf =
Migration distance: from origin to centre of spot
Development distance: from origin to solvent front
Table 2.  Results  (expressed as Rf  x  100)*
Compound Developing  system
System A System B
Methaqualone 40 74
Mecloqualone 30 74
Cocaine 52 67
Heroin 19 46
Diphenhydramine 56 55
Caffeine 5 63
Diazepam 29 75
  
* It is very common to express Rf as Rf x 100
Analytical notes
• Rf values are not always reproducible due to small changes in plate 
 composition and activation, in solvent systems, tank saturation or 
 development distance. Therefore, the Rf values provided are indications 
of the chromatographic behaviour of the substances listed.
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4.2.4   Gas  chromatography  (GC) with flame  ionization   detection 
(GC-FID)
The GC instrument of choice for routine analytical work is the narrow bore capillary 
gas chromatograph, using columns with internal diameter between 0.2 and 0.32 mm. 
However, in view of methods which are in use in a number of drug testing laboratories, 
non-capillary methods (i.e, IDs of 4 mm, methods B and C) for the analysis of meth-
aqualone/mecloqualone are provided in this section.
Methods  [5,6]
Preparation of internal standard solution
Dissolve tetraphenylethylene (or one of the n-alkanes) in dichloromethane to give a 
concentration of 4 mg/ml. Each analysis requires 5.0 ml.
Preparation of the standard solution
Accurately weigh 20 mg of methaqualone HCl (or mecloqualone HCl) standard and 
transfer quantitatively into a 10 ml Erlenmeyer flask. Accurately transfer 5.0 ml of inter-
nal standard solution to the flask followed by 2 ml of 1M sodium bicarbonate solution. 
Place the flask on a steam bath for 5-8 minutes, cool to room temperature, stopper and 
shake the flask. Allow the layers to separate and inject 1-2 µl of the dichloromethane 
layer (bottom layer) into the gas chromatograph.
Preparation of sample solution
Obtain a representative sample from the powder, tablets or capsules (refer to section 4.1 
Sampling). Grind it to a fine powder. Accurately weigh a quantity of sample contain-
ing approximately 20 mg of methaqualone HCl (or mecloqualone HCl) and transfer 
quantitatively to a 10 ml Erlenmeyer flask.
Accurately transfer 5.0 ml of internal standard solution to the flask followed by 2 ml 
of 1M sodium bicarbonate solution. Place the flask on a steam bath for 5-8 minutes, 
cool to room temperature, stopper and shake the flask. Allow the layers separate and 
inject 1-2 µl of the dichloromethane layer (bottom layer) into the gas chromatograph.
• It is essential that reference standards be run simultaneously on the same 
plate.
• For identification purposes, both the Rf value and the colour of the spots 
after spraying with the appropriate visualization reagents should always 
be considered.
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The percentage of methaqualone HCl (or mecloqualone HCl) in the sample can be 
calculated using the general formula below:
Content (%) = Wsampcalc x 100
Wsampnom
where
Wsampcalc =
PARsam
x Wstd = calculated weight of analyte in the sample
PARstd
Wstd = calculated weight of analyte in the sample
Wsampnom = nominal amount of sample used in preparation of the sample solution
PARstd =
Area of methaqulone peak in standard solution
and
Area of internal standard peak in standard solution
PARsamp =
Area of methaqulone peak in standard solution
Area of internal standard peak in standard solution
Method A—capillary  column
GC operating conditions:
Detector:  FID
Column:   Fused silica, chemically bonded and cross-linked methyl 
silicone or methylphenylsilicone, such as OV-1, SE-54, 
BP-1, DB-1 or equivalent, 25 m, 0.25 mm ID, 0.25 µm 
film thickness
Carrier gas:  Nitrogen 1 ml/min
Split ratio:  20:1
Colum temp.: 250°C
Injector/detector temp:  275°C
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Table 3.  Results
Compound  DB-1  (retention  indices)
Methaqualone 2135 (4.0 min)
Mecloqualone 2236 (4.8 min)
Caffeine 1796
Cocaine 2173
Diazepam 2431
Diphenhydramine 1900
Heroin 2577
Tetraphenylethylene 2442 (7.1 min)
Method B—packed  column  technique
GC operating conditions:
Method C—packed  column  technique
GC operating conditions:
Detector:  FID
Column:   10% OV-101 on 100-120 mesh gas Chrom Q , 1.8 m, 
4 mm ID glass
Carrier gas:  Nitrogen 60 ml/min
Column temp:  Initial temperature 150°C for 3 minutes; rate 20°C/
min; final temperature 280°C
Injector/detector temp:  275°C/300°C
Detector:  FID
Column:   3% OV-17 on 100-120 mesh gas Chrom Q, 1.8m, 4 mm 
ID glass
Carrier gas:  Nitrogen 60 ml/min
Column temp:   Initial temperature 150°C for 1 minute; rate 10°C/min; 
final temperature 280°C
Injector/detector temp:  275°C/300°C
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Table 4.  Results  (Methods B and C)  [7]
Compound  Retention  time  (min)
10% OV-101 3% OV-17
Anthranilic acid 5.5 2.9
N-acetylanthranilic acid 8.2 5.3
o-toluidine 1.7 0.7
o-chloroaniline 2.2 0.9
Methaqualone 12.8 10.5
Mecloqualone 13.7 11.5
o-methyl acetanilide 5.7 3.1
o-chloro acetanilide 5.4 2.5
2-methyl-3-o-carboxyphenyl-4-quinazolinone 17.6 14.7
4.2.5  Gas  chromatography–mass  spectrometry  (GC-MS)
GC-MS is one of the most commonly used techniques for the identification of forensic 
drug samples. As a hyphenated technique, it unifies the separation power and sensitiv-
ity of a GC with the analyte specificity of a spectroscopic technique. It can provide 
high specific spectral data on individual compounds in a complex mixture without 
prior isolation.
Sample preparation and extraction procedure
Samples are pulverized and homogenized with a mortar and pestle. A suitable quantity 
(1 g) of material is transferred into a test tube (10 ml). Chloroform (5 ml) is added and 
the mixture vortexed for 10 seconds. The supernatant is filtered through anhydrous 
sodium sulfate, an aliquot of the supernatant (1 µl) is then transferred to a sample vial 
(2 ml). The sample is reduced to dryness under a stream of nitrogen and the residue 
reconstituted in chloroform (1 ml) prior to GC/MS analysis.
Preparation of  standard  solutions
Prepare a standard solution of methaqualone at a concentration of 100 mg/ml in 
 chloroform.
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GC-MS operating conditions [8]
Identification is accomplished by comparing the retention time and mass spectrum of 
the analyte with that of a reference standard. All compounds identified by GC-MS and 
reported by the analyst must be compared to a current mass spectrum of the appropriate 
reference standard, preferably obtained from the same instrument, operated under the 
same conditions. Commercial mass spectral libraries or user generated spectra should 
be used for reference purposes only. Quantification can be done by using IS method 
(refer to 4.2.4).
The principal ions in the mass spectrum of methaqualone are m/z 235, 250, 91, 233, 
236, 65, 76, 132
Table 5.  Results of GC-MS analysis
Compound  Retention  time  (min)
Methaqualone 12.2
Diphenhydramine 15.2
Cocaine 15.1
Diazepam 17.2
N-Acetylanthranilic acid 10.5
Anthranilic acid 6.8
GC oven conditions:   Column temperature initially set at 100°C and ramped 
immediately after injection to 280°C at a rate of 10°C/
min with a final isotherm of 5 minutes.
Column: DB-5MS, HP-5MS , 30 m x 250 µm; df 0.25 µm
Inlet:  Mode: splitless (splitter vented 1.5 min);  
Temperature = 250°C
 Carrier gas: helium, 1ml/min, constant flow.
Detector:   Ionization mode: EI mode, 70 eV; Transfer line temp: 
280°C; Ion source temperature: 230°C
MS parameters:   Solvent delay 4.00 minutes; Scan parameters: TIC, 
scan range: 40 – 450 m/z
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Compound  Retention  time  (min)
Acetanthranil 6.5
o-methyl acetanilide 7.4
o-toluidine 5.7
4.2.6  High performance  liquid  chromatography  (HPLC)
All materials for the sample and standard solutions are prepared in the mobile phase 
to produce final concentrations of approximately 1 mg/ml. Quantitation is achieved 
by the external standard method using analyte peak areas (refer to section 4.2.4 Gas 
chromatography (GC) with flame ionization detection GC-FID).
Chromatographic conditions [9]
Table 6.  Results of HPLC analysis
Compound  Capacity  factor  (k)
Methaqualone 5.1
Mecloqualone 6.1
Caffeine 1.1
Cocaine 7.9
Diazepam 9.9
Diphenhydramine 13.8
Heroin 4.3
Column: ODS Hypersil (or equivalent), 250 mm x 4.6 mm ID
Mobile phase:  Acetonitrile: 1% ammonium acetate solution : 2.5% 
aqueous diethylamine
  (40:45:15 by volume; adjust pH to 8-9 units by addition 
of ammonia or acetic acid)
Flow rate: 1.5 ml/min
Detection: UV at 254 nm
Injection volume: 5 µl
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4.2.7  Fourier  transform  infrared  (FTIR)  spectroscopy
The confirmation of the identity of a substance can be achieved by FTIR. Unequivocal 
identification of methaqualone and mecloqualone is thus possible from each unique 
spectrum. For powders, considered from prior chromatographic analysis to be reason-
ably pure, the infrared spectrum of the powder may be run directly in a KBr disc for 
comparison with those of methaqualone or mecloqualone free bases or HCl salts. For 
tablets, capsules and mixture of powders, an extraction procedure would be required 
to liberate the free base in a pure form.
Result [5, 10]
Methaqualone: Principal peaks at wave numbers: 1682, 1599, 1565, 770, 1265, 697 
(KBr disk)
Mecloqualone: Principal peaks at wave numbers: 1682, 1605, 768, 782, 1282, 1583 
(KBr disk)
The IR spectra of methaqualone and mecloqualone are quite similar except for the 
“fingerprint” region from 1300 to 625 cm-1. Mecloqualone can be recognized by its 
strong absorption at 1275.
4.2.8  Ultraviolet  (UV)  spectrophotometry
Methaqualone and mecloqualone show the following absorption peaks in aqueous acid 
and alkaline media.
Aqueous acid: 234 nm (A (1% 1 cm) = 1320), 269 nm.
Aqueous alkali: 265 nm (A (1% 1 cm) = 347), 306 nm.
Analytical notes
• The KBr disc method consists of grinding a dry sample to a very fine pow-
der, then mixing about 1 mg of homogenized sample powder with 200 mg 
of carefully dried and ground KBr. After grinding, the mixture is pressed 
into a thin transparent disk.
• KBr should be “IR Grade” and dried at 110°C for a minimum of one hour. 
It can be stored in a dessicator containing a strong desiccant (silica gel) or 
left in the oven and removed when required
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